|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai R, Wang P, Zhao X, Lu X, Deng R, Wang
X, Su Z, Hong C and Lin J: LTBP1 promotes esophageal squamous cell
carcinoma progression through epithelial-mesenchymal transition and
cancer-associated fibroblasts transformation. J Transl Med.
18:1392020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xi M, Yang Y, Zhang L, Yang H, Merrell KW,
Hallemeier CL, Shen RK, Haddock MG, Hofstetter WL, Maru DM, et al:
Multi-institutional analysis of recurrence and survival after
neoadjuvant chemoradiotherapy of esophageal cancer: Impact of
histology on recurrence patterns and outcomes. Ann Surg.
269:663–670. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baughman JM, Perocchi F, Girgis HS,
Plovanich M, Belcher-Timme CA, Sancak Y, Bao XR, Strittmatter L,
Goldberger O, Bogorad RL, et al: Integrative genomics identifies
MCU as an essential component of the mitochondrial calcium
uniporter. Nature. 476:341–345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vultur A, Gibhardt CS, Stanisz H and
Bogeski I: The role of the mitochondrial calcium uniporter (MCU)
complex in cancer. Pflugers Arch. 470:1149–1163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hall DD, Wu Y, Domann FE, Spitz DR and
Anderson ME: Mitochondrial calcium uniporter activity is
dispensable for MDA-MB-231 breast carcinoma cell survival. PLoS
One. 9:e968662014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tosatto A, Sommaggio R, Kummerow C,
Bentham RB, Blacker TS, Berecz T, Duchen MR, Rosato A, Bogeski I,
Szabadkai G, et al: The mitochondrial calcium uniporter regulates
breast cancer progression via HIF-1α. EMBO Mol Med. 8:569–585.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren T, Zhang H, Wang J, Zhu J, Jin M, Wu
Y, Guo X, Ji L, Huang Q, Zhang H, et al: MCU-dependent
mitochondrial Ca2+ inhibits NAD(+)/SIRT3/SOD2 pathway to
promote ROS production and metastasis of HCC cells. Oncogene.
36:5897–5909. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Sun Q, Zhou D, Song W, Yang Q, Ju
B, Zhang L, Xie H, Zhou L, Hu Z, et al: HINT2 triggers
mitochondrial Ca2+ influx by regulating the
mitochondrial Ca2+ uniporter (MCU) complex and enhances
gemcitabine apoptotic effect in pancreatic cancer. Cancer Lett.
411:106–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koval OM, Nguyen EK, Santhana V, Fidler
TP, Sebag SC, Rasmussen TP, Mittauer DJ, Strack S, Goswami PC, Abel
ED and Grumbach IM: Loss of MCU prevents mitochondrial fusion in
G1-S phase and blocks cell cycle progression and proliferation. Sci
Signal. 12:eaav14392019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sawaguchi A, McDonald KL and Forte JG:
High-pressure freezing of isolated gastric glands provides new
insight into the fine structure and subcellular localization of
H+/K+-ATPase in gastric parietal cells. J Histochem Cytochem.
52:77–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsieh CC, Hsu HS, Li AF and Chen YJ:
Clinical relevance of PD-L1 and PD-L2 overexpression in patients
with esophageal squamous cell carcinoma. J Thorac Dis.
10:4433–4444. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang W, Han Y, Zhao X, Duan L, Zhou W,
Wang X, Shi G, Che Y, Zhang Y, Liu J, et al: Advances in prognostic
biomarkers for esophageal cancer. Expert Rev Mol Diagn. 19:109–119.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Wang Q, Shen S, Wei X and Li G:
HIF-1α/VEGF signaling-mediated epithelial-mesenchymal transition
and angiogenesis is critically involved in anti-metastasis effect
of luteolin in melanoma cells. Phytother Res. 33:798–807. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okadome K, Baba Y, Yagi T, Kiyozumi Y,
Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M and Baba
H: Prognostic nutritional index, tumor-infiltrating lymphocytes,
and prognosis in patients with esophageal cancer. Ann Surg.
271:693–700. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dubecz A, Kern M, Solymosi N, Schweigert M
and Stein HJ: Predictors of lymph node metastasis in surgically
resected T1 esophageal cancer. Ann Thorac Surg. 99:1879–1886. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qu J, Shen C, Qin J, Wang Z, Liu Z, Guo J,
Zhang H, Gao P, Bei T, Wang Y, et al: The MR radiomic signature can
predict preoperative lymph node metastasis in patients with
esophageal cancer. Eur Radiol. 29:906–914. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Al-Kaabi A, van der Post RS, Huising J,
Rosman C, Nagtegaal ID and Siersema PD: Predicting lymph node
metastases with endoscopic resection in cT2N0M0 oesophageal cancer:
A systematic review and meta-analysis. United European
Gastroenterol J. 8:35–43. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Li M, Liu G, Zhang X, Zhi L, Zhao J
and Wang G: The function of Piezo1 in colon cancer metastasis and
its potential regulatory mechanism. J Cancer Res Clin Oncol.
146:1139–1152. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Luo A, Huang F, Gong T and Liu Z:
SERPINE2 promotes esophageal squamous cell carcinoma metastasis by
activating BMP4. Cancer Lett. 469:390–398. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu X, Lin J, Jiang M, He X, Wang K, Wang
W, Hu C, Shen Z, He Z, Lin H, et al: HIF-1α promotes the metastasis
of esophageal squamous cell carcinoma by targeting SP1. J Cancer.
11:229–240. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin
HL, Wang L, Wang P, He GJ, Hao B and Shi RH: HIF-1α induces
VE-cadherin expression and modulates vasculogenic mimicry in
esophageal carcinoma cells. World J Gastroenterol. 20:17894–17904.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Y, Zang Y, Zhao F, Li Z, Zhang J, Fang
L, Li M, Xing L, Xu Z and Yu J: Inhibition of HIF-1alpha by PX-478
suppresses tumor growth of esophageal squamous cell cancer in vitro
and in vivo. Am J Cancer Res. 7:1198–1212. 2017.PubMed/NCBI
|
|
24
|
Chen M, Cai E, Huang J, Yu P and Li K:
Prognostic value of vascular endothelial growth factor expression
in patients with esophageal cancer: A systematic review and
meta-analysis. Cancer Epidemiol Biomarkers Prev. 21:1126–1134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng J, Shao N, Peng H and Chen LQ:
Prognostic significance of vascular endothelial growth factor
expression in esophageal carcinoma: A meta-analysis. J Buon.
18:398–406. 2013.PubMed/NCBI
|
|
26
|
Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee
NPY, Law S, Xu LY, Li EM, Chan KW, et al: MicroRNA-377 suppresses
initiation and progression of esophageal cancer by inhibiting CD133
and VEGF. Oncogene. 36:3986–4000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin T, Liu W, Huo J, Li L, Zhang X, Shi X,
Zhou J and Wang C: SIRT1 expression regulates the transformation of
resistant esophageal cancer cells via the epithelial-mesenchymal
transition. Biomed Pharmacother. 103:308–316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taniguchi D, Saeki H, Nakashima Y, Kudou
K, Nakanishi R, Kubo N, Ando K, Oki E, Oda Y and Maehara Y: CD44v9
is associated with epithelial-mesenchymal transition and poor
outcomes in esophageal squamous cell carcinoma. Cancer Med.
7:6258–6268. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nahomi RB and Nagaraj RH: The role of
HIF-1α in the TGF-β2-mediated epithelial-to-mesenchymal transition
of human lens epithelial cells. J Cell Biochem. 119:6814–6827.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yeh YH, Hsiao HF, Yeh YC, Chen TW and Li
TK: Inflammatory interferon activates HIF-1α-mediated
epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway. J
Exp Clin Cancer Res. 37:702018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Zhang Q, Lou Y, Fu Q, Chen Q, Wei
T, Yang J, Tang J, Wang J, Chen Y, et al: Hypoxia-inducible
factor-1alpha/interleukin-1beta signaling enhances hepatoma
epithelial-mesenchymal transition through macrophages in a
hypoxic-inflammatory microenvironment. Hepatology. 67:1872–1889.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palumbo A Jr, Meireles Da Costa N, Pontes
B, Leite de Oliveira F, Lohan Codeço M, Ribeiro Pinto LF and
Nasciutti LE: Esophageal cancer development: crucial clues arising
from the extracellular matrix. Cells. 9:4552020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Uraoka N, Oue N, Sakamoto N, Sentani K, Oo
HZ, Naito Y, Noguchi T and Yasui W: NRD1, which encodes nardilysin
protein, promotes esophageal cancer cell invasion through induction
of MMP2 and MMP3 expression. Cancer Sci. 105:134–140. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li L, Yue GG, Lee JK, Wong EC, Fung KP, Yu
J, Lau CB and Chiu PW: The adjuvant value of Andrographis
paniculata in metastatic esophageal cancer treatment-from
preclinical perspectives. Sci Rep. 7:8542017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xuan X, Li S, Lou X, Zheng X, Li Y, Wang
F, Gao Y, Zhang H, He H and Zeng Q: Stat3 promotes invasion of
esophageal squamous cell carcinoma through up-regulation of MMP2.
Mol Biol Rep. 42:907–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kromer C, Xu J, Ostrom QT, Gittleman H,
Kruchko C, Sawaya R and Barnholtz-Sloan JS: Estimating the annual
frequency of synchronous brain metastasis in the United States
2010–2013: A population-based study. J Neurooncol. 134:55–64. 2017.
View Article : Google Scholar : PubMed/NCBI
|
